Home      Portfolio      Strategy      Team      News & Events      Contact Us   
Print
Portfolio
Cleantech
Consumer and Services
Financial Healthcare Internet Mobile Retail Systems Integration
Enterprise Infrastructure
Compute / Data Center Management Networking Security Storage
Enterprise Software
Applications SaaS
Semiconductor
EDA Networking Wireless
Location
United States India Israel
List
Current Investments Recent Investments All Investments
Search
American Medical Systems

Urology products

Status: Acquired by Pfizer in 1985
Funded: 1980 Howard Cox
Amisys Managed Care

HMO management software

Status: IPO 1995
Funded: 1994 Howard Cox
Arbor Health Care

Sub acute care provider

Status: IPO 1993, Acquired by Extendicare in 1997
Funded: 1985 Howard Cox


AVEO Pharmaceuticals

Cancer therapeutics

Status: Private
Funded: 2002 Bill Helman
Biomedical Resources

Clinical labs

Status: IPO 1969, Acquired by SmithKline in 1988
Funded: 1968 Charlie Waite
BioSurface Technology

Medical products to treat tissue damage

Status: IPO 1993, Acquired by Genzyme in 1995
Funded: 1987 Dan Gregory
Cairnstone

Catastrophic care management

Status: Private
Funded: 1996 Howard Cox


Centene

Medicaid focused HMO

Status: IPO 2001
Funded: 1993 Howard Cox
Centocor

Monoclonal antibody based therapeutic and diagnostic products

Status: IPO 1982, Acquired by Johnson & Johnson in 1999
Funded: 1981 Charlie Waite
Chrysalis International

Pre-clinical testing services

Status: IPO 1991
Funded: 1988 Bill Elfers
Cobe Laboratories

Open heart/kidney dialysis equipment

Status: IPO 1972, Acquired by Gambro, AB in 1990
Funded: 1969 Charlie Waite
CompDent

Pre-paid dental health plan

Status: Acquired by APPS in 1995
Funded: 1992 Howard Cox


Concert Pharmaceuticals

Small molecule pharmaceuticals

Status: Private
Funded: 2006 Bill Helman


Exact Sciences

Oncology diagnostics

Status: IPO 2001
Funded: 1996 Bill Helman
Genetics Institute

Protein-based therapeutics

Status: IPO 1986, Acquired By American Home Products in 1997
Funded: 1980 Dan Gregory


Haemonetics

Blood separation equipment

Status: IPO 1979
Funded: 1974 Charlie Waite


Hill Top Research

Clinical research services

Status: Private
Funded: 1997 Howard Cox
HPR

Integrated clinical software solutions

Status: IPO 1995, Acquired by HBO & Company in 1997
Funded: 1991 Howard Cox
Immulogic

Allergy and auto-immune products

Status: IPO 1991
Funded: 1987 Henry McCance


Landacorp

Clinical resource management systems

Status: IPO 2000, Acquired by SHPS in 2004
Funded: 1998 Howard Cox
Lunar

Bone diagnostic equipment

Status: IPO 1990, Acquired by GE Medical Systems in 2000
Funded: 1986 Howard Cox


Managed Comp

Managed worker's compensation

Status: Private
Funded: 1996 Howard Cox
Meditech

Hospital information systems

Status: Private
Funded: 1986 Howard Cox


Millennium Pharmaceuticals

Gene-based therapeutics

Status: IPO 1996
Funded: 1993 Bill Helman


Millipore

Separation/filtration equipment

Status: IPO 1987
Funded: 1969 Dan Gregory
Mitotix

Cell cycle / proliferation therapeutics

Status: Acquired by GPC Biotech AG in 2000
Funded: 1992 Bill Helman
Molecular Design

Databases for chemical research

Status: Acquired by Maxwell-Macmillan in 1987
Funded: 1983 David Strohm
Molecular Dynamics

Instrumentation for life science research

Status: IPO 1993, Acquired by Nycomed Amersham in 1998
Funded: 1992 David Strohm
Neurex

Therapeutic products for cardiorenal and neurological diseases

Status: IPO 1993, Acquired by Elan in 1998
Funded: 1987 Bill Helman


Neutrogena

Dermatology

Status: IPO 1973
Funded: 1973 Charlie Waite
Ontogeny

Developmental biology

Status: Merged with Creative BioMolecules to create Curis in 2000
Funded: 1994 Bill Helman
Oxford Labs

Disposable medical products

Status: IPO 1973, Acquired by G.D. Searle in 1974
Funded: 1970 Charlie Waite
Pharmacopeia

Small molecule combinatorial chemistry

Status: IPO 1995
Funded: 1994 Bill Helman
Phycor Management Corporation

Physician practice management

Status: Acquired by Phycor in 1998
Funded: 1995 Howard Cox


Praecis Pharmaceuticals

Peptide screening for drugs

Status: IPO in 2000, Acquired by GSK in 2006
Funded: 1993 Henry McCance
Pryon

CO2 analyzer

Status: Acquired by Protocol in 1996
Funded: 1990
Rehab Systems

Rehabilitation hospitals

Status: Acquired by Novacare in 1991
Funded: 1987 Howard Cox
Respiratory Care

Disposable medical products

Status: Acquired by Colgate in 1977
Funded: 1973 Henry McCance


SCIREX

Clinical Research Organization

Status: Private
Funded: 1996 Bill Helman
Share Development

HMO

Status: Acquired by United Healthcare in 1985
Funded: 1983 Howard Cox
Spacelabs

Monitoring equipment

Status: Acquired by Squibb in 1980
Funded: 1973 Charlie Waite


Stryker

Orthopedics focused medical devices

Status: IPO 1979
Funded: 1974 Howard Cox
TravCorps

Health care staffing services

Status: Private
Funded: 1995 Howard Cox


Vertex Pharmaceuticals

Structure-based drug design

Status: IPO 1991
Funded: 1989 Bill Helman
VHA Long Term Care

Nursing home management

Status: Acquired by ServiceMaster in 1993
Funded: 1992 Howard Cox


Vivra Specialty Partners

Specialty focused physician practice management

Status: Private
Funded: 1997 Howard Cox
Worthington Biochemical

Enzymes

Status: IPO 1971, Acquired by Millipore in 1975
Funded: 1967 Dan Gregory


Xoma

Infectious and immune-system drugs

Status: IPO 1986
Funded: 1981 Charlie Waite
© Copyright 2008 Greylock Partners. All rights reserved.  Powered by Broadchoice